Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $30.90 is 10.83% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 31.74||$ 44.5613|
|Low:||$ 30.66||$ 27.88|
ETFs with PFE as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.59%||First Trust Nasdaq Pharmaceuticals ETF (FTXH)||-1.98 (-9.53%)|
|5.99%||iShares Core High Dividend ETF (HDV)||-22.38 (-23.62%)|
|5.55%||WisdomTree U.S. High Dividend Fund (DHS)||-17.61 (-23.50%)|
|5.49%||SPDR Select Sector Fund - Health Care (XLV)||-7.90 (-8.34%)|
|5.36%||John Hancock Multifactor Healthcare ETF (JHMH)||-2.32 (-6.75%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture and distribution of healthcare products, including innovative medicines and vaccines. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Our revenues are derived from the sale of our products and, to a much lesser extent, from alliance agreements, under which we co-promote products discovered or developed by other companies or us. The majority of our revenues come from the manufacture and sale of biopharmaceutical products. ... More ...